Please login to the form below

Not currently logged in
Email:
Password:

Road wins Helperby Therapeutics account

Agency will provide communications support to the antibiotics firmN

ROADLondon-based healthcare comms agency Road has been appointed by Helperby Therapeutics to provide communications around its work on antimicrobial resistance.

Road will be launching offline, digital and social media programmes to engage the medical and investment communities in conversations around antibiotics and resistance.

Helperyby is working on antiobiotic technology that it hopes will battle microbial resistance by combining new resistance breakers with existing antibiotics to create a “new generation of therapies”.

Frances Crewsdon, chief operating officer at Helperby, said: “There has been no new class of antibiotic produced over thirty years.

“This new lease of life for antibiotics has the potential to help sustain our defence against life threatening superbugs for years to come.”

The threat of antimicrobial resistance continues to attract a high-level response, most recently with the EU bringing together stakeholders across Europe last month to define common policies to fight AMR and control hospital-acquired infections.

Article by
Gemma Jones

2nd October 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics